Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
| Fund | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| NTRA | +85.26% | +2.67% | +7.52% | +3.07% | +68.27% | +112.03% | +123.89% | +1,009.30% | +262.13% | +292.91% |
| SCBGENOME(E) | +84.46% | +8.17% | +11.73% | +2.83% | +41.58% | +76.38% | +76.75% | +128.29% | −37.88% | −40.63% |
| TGENOME | +71.74% | +7.65% | +11.05% | +2.74% | +38.71% | +68.66% | +66.81% | +108.03% | −40.86% | −43.49% |
| BCAP-XHEALTH | +20.18% | +1.90% | +5.53% | +0.43% | +6.60% | +23.32% | +15.56% | +26.68% | −28.58% | −29.92% |
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
Excludes NTRA: money market or bond funds, or no holdings data yet
| SCBGENOME(E) | TGENOME | |
|---|---|---|
| Held by both | ||
 Twist Bioscience | 10.03% | 8.90% |
 10x Genomics | 8.02% | 7.84% |
 Tempus AI | 7.15% | 6.99% |
 CRISPR Therapeutics | 4.20% | 4.10% |
 Absci | 4.05% | 3.96% |
| Personalis | 3.91% | 3.82% |
 Natera | 3.63% | 3.92% |
 Guardant Health | 3.69% | 3.61% |
 Illumina | 3.60% | 3.80% |
 CareDx | 3.48% | 3.40% |
30 Dec 2025 → 28 Oct 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| SCBGENOME(E) | +84.46% | 42.00% | 2.01 |
| TGENOME | +71.74% | 39.73% | 1.81 |
| NTRA | +85.26% | 51.74% | 1.65 |
| BCAP-XHEALTH | +20.18% | 19.56% | 1.03 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | NTRA | SCBGENOME(E) | TGENOME | BCAP-XHEALTH |
|---|---|---|---|---|
Fund details | ||||
| Fund size | N/A | 44.29 million | 1,343 million | 470 million |
| Inception date | N/A | 20 Aug 2021 | 13 Jan 2021 | 14 May 2021 |
| Master fund | N/A | กองทุน ARK Genomic Revolution ETF | กองทุนที่ลงทุนหลายกอง (ARK Genomic Revolution, iShares Genomics Immunology and Healthcare, ISHARES BIOTECHNOLOGY) | กองทุนที่ลงทุนหลายกอง |
| Dividend policy | N/A | Does not pay | Does not pay | Does not pay |
Risk and currency hedging | ||||
| Risk level | N/A | 7 | 7 | 6 |
| Hedging policy | N/A | Hedged at the manager's discretion | Hedged at the manager's discretion | Hedged at the manager's discretion |
| Share hedged | N/A | 57.68% | 84.93% | N/A |
Minimum purchase and redemption | ||||
| First purchase | N/A | 1 THB | 1,000 THB | 500 THB |
| Subsequent purchase | N/A | 1 THB | 1,000 THB | 500 THB |
| Redemption (amount) | N/A | 1 THB | No minimum | No minimum |
| Redemption (units) | N/A | No minimum | No minimum | No minimum |
| Balance (amount) | N/A | 1 THB | No minimum | No minimum |
| Balance (units) | N/A | No minimum | No minimum | No minimum |
Order cut-off and redemption payment | ||||
| Buy before | N/A | 15:30 | 15:30 | 15:30 |
| Redeem before | N/A | 15:30 | 15:30 | 15:30 |
| Redemption paid | N/A | T+4 | T+3 | T+3 |
